-
WESTBURY, NY - Jun 3, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a HEPATOPAC Meeting at the AC Hotel by Marriott, San Francisco Airport/Oyster Point Waterfront on June 7
Jun 3, 2019
-
GUILDFORD, UNITED KINGDOM - May 24, 2019 - MR Solutions high field simultaneous PET-MR systems and large bore, 7T cryogen free MRI technology were seen to be game-changers by leading molecular imaging researchers at the 27th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM)[i], in Montreal last week
May 30, 2019
-
KIRKLAND, WA, UNITED STATES - May 30, 2019 - Resolution Bioscience, Inc., today announced that the Resolution HRD liquid biopsy assay has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA)
May 30, 2019
-
WESTBURY, NY - May 29, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology research
May 29, 2019
-
PRINCETON, NJ - May 28, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the introduction of Certara Integral, its next-generation data repository for collecting, managing, and storing multiple types of data sets for analysis, sharing and reporting of clinical pharmacology, pharmacometrics and other relevant clinical data
May 28, 2019
-
MENLO PARK, CA - May 23, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced today the addition of William F
May 23, 2019
-
SUFFERN, NY, UNITED STATES - May 18, 2019 - CDx Diagnostics®, innovator of the WATS3D® diagnostic tissue test for the detection and surveillance of Barretts esophagus (BE), a known precursor to esophageal adenocarcinoma (EAC), today announced positive results from a clinical study evaluating WATS3D (Wide Area Transepithelial Sampling with 3D Tissue Analysis) in detecting residual/recurrent intestinal metaplasia (RRIM) in patients who have undergone BE ablation
May 21, 2019
-
NEWARK, CA, UNITED STATES - May 21, 2019 - NEWARK, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases, today announced results related to its seladelpar clinical development program for the treatment of primary biliary cholangitis (PBC)
May 21, 2019
-
PRINCETON, NJ - May 20, 2019 - The WIRB-Copernicus Group® (WCG) announced today that David Borasky, MPH, CIP, its vice president, IRB Compliance will be leading an educational session on the revised Common Rule at the Association for the Accreditation of Human Research Protection Programs, Inc
May 20, 2019
-
PRINCETON, NJ - May 16, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced today that it has appointed Dr
May 16, 2019
-
GUILDFORD, UK - May 14, 2019 - In a paper published in the American Chemical Society journal researchers from Bourgogne University showed that the use of superparamagnetic iron oxide nanoparticles (NPs) using multi modal – PET/MRI - showed promising improvements in imaging capabilities
May 14, 2019
-
WESTBURY, NY - May 2, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that its ADME-Tox team has co-authored a second peer-reviewed paper investigating the potential for clinically-relevant botanical-drug interactions (BDIs) with toxicology colleagues at The Procter & Gamble Company (P&G)
May 2, 2019
-
ROYAL OAK, MI, UNITED STATES - Apr 30, 2019 - OncoCell MDx, a company developing novel noninvasive diagnostic and prognostic tests by harnessing the power of the immune system, today announced the appointment of Mark McDonough as its president, chief executive officer (CEO) and member of the Board of Directors
Apr 30, 2019
-
OXFORD, UNITED KINGDOM, UNITED KINGDOM - Apr 30, 2019 - The significant demand for inflammatory marker laboratory tests in general practice highlights an untapped opportunity for point-of-care diagnostics in the community, suggests research from the NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative
Apr 30, 2019
-
MENLO PARK, CA - Apr 29, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced today that Eric Donnenfeld, M
Apr 29, 2019
-
LONDON, UK - Apr 29, 2019 -
A study published in
Science Translational Medicine
documents the role played by Clinithink's patented clinical natural language processing platform in delivering genetic diagnoses to neonatal and pediatric intensive care physicians in record breaking time
A new study, published today in Science Translational Medicine, details the pioneering work undertaken by a collaboration led by Stephen Kingsmore, MD, DSc, President and CEO of Rady Children's Institute for Genomic Medicine (RGIGM)
Apr 29, 2019
-
GUILDFORD, UK - Apr 24, 2019 - MR Solutions, of Guildford has achieved a third Queens Award. This follows their win in 2016 with the Queens Award for Enterprise (Innovation), while in 2017 the company was recognised for their excellent performance in International Trade
Apr 24, 2019
-
PRINCETON, NJ - Apr 17, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced four senior executive appointments in its Simcyp division
Apr 17, 2019
-
PRINCETON, NJ - Apr 12, 2019 - The WIRB-Copernicus Group® (WCG) is pleased to announce the addition of several prominent executives to its Site Division and the expansion of its Global Research Network (GRN) of investigative sites
Apr 12, 2019
-
PRINCETON, NJ - Apr 4, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division announces the acquisition of Analgesic Solutions, LLC, the global leader in the development of new pain medications and in the support of clinical trials in which pain is an indicator of an underlying condition
Apr 4, 2019